Skip to main content
main-content

08-05-2019 | Parkinson's disease | Video

AAN 2019: LRRK2, GBA carriers exhibit subtle manifestations of Parkinson’s disease

Tatyana Simuni describes the clinical and imaging features of LRRK2 and GBA mutation carriers participating in the Parkinson's Progression Markers Initiative cohort (6:29).

Funding for independent interviews at AAN 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.